Soaring Demand Set to Propel Genome Editing/Genome Engineering Market to $20.64 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Genome Editing/Genome Engineering Market Through 2025?
The overall scale of the genome editing and genome engineering sector has experienced swift expansion lately, projected to increase from its 2024 valuation of $8.62 billion to $10.17 billion by 2025, reflecting a substantial compound annual growth rate (CAGR) of 17.9%; this past period's upward trajectory is largely owing to the intensified focus on genetic and genomic investigations, a greater incidence of hereditary illnesses, progress in gene therapy modalities, heightened capital injection into biotech and life sciences, the prospective utility within agriculture, and utilization within study organisms.

What's the Projected Size of the Global Genome Editing/Genome Engineering Market by 2029?
Anticipated for substantial expansion in the near future, the scope of the genome editing and genome engineering sector is projected to reach a valuation of $20.64 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 19.4% throughout the projection timeframe; this significant upward trajectory is fueled by the appearance of prime editing techniques, a heightened concentration on establishing ethical guidelines and regulatory structures, the widening acceptance within drug discovery processes, the profound therapeutic possibilities for inherited illnesses, the capacity to tailor modifications for studying gene functions, and escalating attention towards altering the epigenome. Key developments expected to shape this period involve progress within Crispr technologies, continually broadening therapeutic uses, the introduction of novel genome editing instruments, increased funding combined with strategic alliances, improvements in delivery mechanisms, and the incorporation of artificial intelligence (AI) for refining genome editing strategies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

Top Growth Drivers in the Genome Editing/Genome Engineering Industry: What's Accelerating the Market?
Anticipated increases in the occurrence rates of cancer and various other hereditary conditions are projected to fuel the expansion of the genome editing, also known as genome engineering, market moving ahead. Cancer is characterized by the uncontrollable proliferation and subsequent dissemination of a subset of the body's cells to distant anatomical sites, and genome editing technologies offer a rapid means to modify immune cells and oncolytic viruses specifically for oncology treatments. As an illustration of its global impact, cancer was responsible for approximately ten million fatalities, translating to roughly one out of every six global deaths, placing it as the primary cause of mortality worldwide by February 2022, as reported in documentation from the World Health Organization (WHO), the specific health entity affiliated with the United Nations and headquartered in Switzerland. Furthermore, the United States saw a total of 1,752,735 new diagnoses of invasive cancer in 2019, encompassing 863,830 cases among women and 888,905 among men, according to data surfaced by the Centers for Disease Control and Prevention (CDC), the national public health body in the US, in a June 2022 publication, with the overall incidence rate for all cancer types registering at 439 per 100,000 individuals within the populace; consequently, this increasing frequency of cancer and other inherited ailments serves as a significant impetus for the market progression in genome editing and genome engineering endeavors.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp

What Trends Will Shape the Genome Editing/Genome Engineering Market Through 2029 and Beyond?
A significant factor shaping the genome editing and genome engineering market is the escalating adoption of sophisticated technological progress within gene editing methodologies. Leading entities within this sector are channeling their efforts into developing novel technological approaches with the goal of strengthening their market standing. To illustrate, a significant development occurred in May 2022 when scientists affiliated with Kyoto University alongside the Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra), a Spanish institution specializing in evolutionary studies, introduced a rapid and highly efficient means of altering genes specifically in insects. This new, straightforward, and potent approach, termed Direct Parental CRISPR (DIPA-CRISPR), bypasses the need for microinjecting materials into embryos by instead administering the necessary components into the eggs of mature female insects that are currently developing. Subsequently, this innovative process eliminates the necessity for researchers to perform microinjections of CRISPR components directly into insect embryos.

What Are the Main Segments in the Genome Editing/Genome Engineering Market?
The genome editing/genome engineeringmarket covered in this report is segmented -

1) By Product And Service: Reagents And Consumables; Software And systems; Services
2) By Technology: CRISPR; TALEN; ZFN; Antisense; Other Technologies
3) By Application: Cell Line Engineering; Genetic Engineering; Diagnostic Applications; Drug Discovery And Development; Other Applications
4) By End User: Biotechnology Companies; Pharmaceutical Companies; Academic And Government Research Institutes

Subsegments:
1) By Reagents And Consumables: CRISPR Or Cas9 Kits; TALENs Kits; Zinc Finger Nucleases (ZFNs); Donor DNA Templates; Nucleotide Reagents
2) By Software And Systems: Genome Editing Design Software; Analysis And Visualization Tools; Workflow Management Systems
3) By Services: Gene Synthesis And Cloning Services; Custom Genome Editing Services; Consulting Services For Genome Editing Projects

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8010&type=smp

Which Top Companies are Driving Growth in the Genome Editing/Genome Engineering Market?
Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.

Which Regions Will Dominate the Genome Editing/Genome Engineering Market Through 2029?
North America was the largest region in the gene editing/genome engineering market in 2024. Asia-Pacific is expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8010

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.